DrugPatentWatch Database Preview
Drugs in Development Information for Tesofensine
» See Plans and Pricing
What is the development status for investigational drug Tesofensine?
Tesofensine is an investigational drug.
There have been 11 clinical trials for Tesofensine.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 30th 2017.
The most common disease conditions in clinical trials are Obesity, Prader-Willi Syndrome, and Alzheimer Disease. The leading clinical trial sponsors are Saniona, NeuroSearch A/S, and Boehringer Ingelheim.
Summary for Tesofensine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 747 |
| WIPO Patent Applications | 943 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2017-03-30) |
| Vendors | 10 |
Recent Clinical Trials for Tesofensine
| Title | Sponsor | Phase |
|---|---|---|
| 48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO) | Saniona | Phase 2 |
| A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate | Saniona | Phase 1 |
| Study to Investigate the Pharmacokinetic Profile | Saniona | Phase 1 |
Clinical Trial Summary for Tesofensine
Top disease conditions for Tesofensine
Top clinical trial sponsors for Tesofensine
US Patents for Tesofensine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
